国际妇产科学杂志 ›› 2011, Vol. 38 ›› Issue (4): 306-310.

• 综述 • 上一篇    下一篇

卵巢癌激素治疗进展

郭 飞,程 炜, 薛凤霞,李冬云   

  1. 300052 天津医科大学总医院妇科
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2011-08-15 发布日期:2011-08-15
  • 通讯作者: 薛凤霞

Advancement in Hormone Therapy of Ovarian Cancer

GUO Fei,CHENG Wei, XUE Feng-xia,LI Dong-yun   

  1. Department of Gynecology,Tianjin Medical University General Hospital,Tianjin 300052,China
  • Received:1900-01-01 Revised:1900-01-01 Published:2011-08-15 Online:2011-08-15
  • Contact: XUE Feng-xia

摘要: 卵巢癌是病死率较高的妇科恶性肿瘤,其发病机制尚不清楚,尽管已有持续排卵假说、炎症假说、间质假说、促性腺激素假说、雄激素/孕激素假说,但无一能阐明所有卵巢癌的问题。卵巢癌的早期诊断困难,约70%的患者就诊时已是晚期,且75%在I期治疗后复发、预后差。对于复发性卵巢癌的补救化疗效果非常有限。流行病学研究及体内体外试验均已证明下丘脑-垂体-卵巢轴释放的类固醇激素可发挥刺激或抑制卵巢癌进展的作用。激素治疗对复发性卵巢癌有一定疗效且不良反应轻微。综述激素(促性腺激素释放激素、促性腺激素、雄激素、孕激素、雌激素)及其受体与卵巢癌的关系及复发性卵巢癌的激素治疗现状。

关键词: 卵巢肿瘤, 癌, 雌激素类, 孕激素类, 雄激素类, 促性腺激素, 治疗

Abstract: Ovarian cancer is one of gynecological malignant tumors which can result in a high mortality. Although many hypotheses have been introduced,such as incessant ovulation,inflammation hypothesis,stroma hypothesis, gonadotropic hormone hypothesis,androgen/progestin hypothesis,the pathogenesis of ovarian cancer is unclear. The early diagnosis of ovarian cancer is very difficult,and approximate 70% tumors are at advanced stage at the time of diagnosis. About 75% tumors will relapse after one stage of treatment,and the prognosis is poor. The remedial chemotherapy for recurrent ovarian cancer has limited effects. Epidemiology study and experiments in vivo and vitro have already demonstrated that the steroid hormone released from hypothalamus-pituitary-ovary axis could promote or inhibit the progression of ovarian cancer. Hormonotherapy has certain curative effects and only some slight side effects.This article will focus on the association between hormone (gonadotropin releasing hormone,gonadotrophin,androgen,progestin and estrogen)and their receptors and ovarian cancer,and the current situation of hormonotherapy for recurrent ovarian cancer.

Key words: Ovarian neoplasms, Carcinoma, Estrogens, Progestins, Androgens, Gonadotrophin